Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 12, 2020

SELL
$21.1 - $29.13 $248,980 - $343,734
-11,800 Closed
0 $0
Q2 2020

Aug 12, 2020

SELL
$18.94 - $24.93 $247,451 - $325,710
-13,065 Reduced 52.54%
11,800 $253,000
Q1 2020

May 12, 2020

BUY
$16.68 - $32.25 $39,615 - $76,593
2,375 Added 10.56%
24,865 $557,000
Q4 2019

Feb 12, 2020

BUY
$25.29 - $29.45 $78,146 - $91,000
3,090 Added 15.93%
22,490 $662,000
Q3 2019

Nov 12, 2019

BUY
$25.62 - $34.96 $224,046 - $305,725
8,745 Added 82.07%
19,400 $516,000
Q3 2019

Nov 12, 2019

SELL
$25.62 - $34.96 $143,215 - $195,426
-5,590 Reduced 34.41%
10,655 $360,000
Q2 2019

Aug 13, 2019

BUY
$31.11 - $34.79 $222,592 - $248,922
7,155 Added 78.71%
16,245 $549,000
Q1 2019

May 03, 2019

BUY
$29.0 - $32.83 $263,610 - $298,424
9,090 New
9,090 $292,000

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $6.63B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Greenwood Capital Associates LLC Portfolio

Follow Greenwood Capital Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenwood Capital Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Greenwood Capital Associates LLC with notifications on news.